BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26140006)

  • 1. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis.
    Shi QQ; Ning XY; Zhan LL; Tang GD; Lv XP
    World J Gastroenterol; 2014 Jun; 20(22):7040-8. PubMed ID: 24944500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis.
    Mazaki T; Masuda H; Takayama T
    Endoscopy; 2010 Oct; 42(10):842-53. PubMed ID: 20886403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.
    Tse F; Yuan Y; Bukhari M; Leontiadis GI; Moayyedi P; Barkun A
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010571. PubMed ID: 27182692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review.
    Choudhary A; Bechtold ML; Arif M; Szary NM; Puli SR; Othman MO; Pais WP; Antillon MR; Roy PK
    Gastrointest Endosc; 2011 Feb; 73(2):275-82. PubMed ID: 21295641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis.
    Afghani E; Akshintala VS; Khashab MA; Law JK; Hutfless SM; Kim KJ; Lennon AM; Kalloo AN; Singh VK
    Endoscopy; 2014 Jul; 46(7):573-80. PubMed ID: 24830399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
    Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
    Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis.
    Mazaki T; Mado K; Masuda H; Shiono M
    J Gastroenterol; 2014 Feb; 49(2):343-55. PubMed ID: 23612857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.